Eliane Sardh

7PUBLICATIONS
9CO-AUTHORS
Gene and molecular therapyHaematological tumoursEpidemiological modellingRespiratory diseasesPsychosocial aspects of childbirth and perinatal mental health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 03, 2024
Long-term follow-up of givosiran treatment in patients with acute intermittent porphyria from a phase 1/2, 48-month open-label extension study.

Eliane Sardh, Manisha Balwani, David C Rees

|Aug 31, 2023
Porphyrin precursors and risk of primary liver cancer in acute intermittent porphyria: A case-control study of 188 patients.

Mattias Lissing, Axel Wester, Daphne Vassiliou

|Apr 20, 2023
Maternal and fetal outcomes in acute hepatic porphyria: A Swedish National Cohort Study.

Ängla Mantel, Daphne Vassiliou, Mattias Lissing

|Dec 22, 2022
Risk for incident comorbidities, nonhepatic cancer and mortality in acute hepatic porphyria: A matched cohort study in 1244 individuals.

Mattias Lissing, Daphne Vassiliou, Ylva Floderus

|Feb 03, 2022
Risk of primary liver cancer in acute hepatic porphyria patients: A matched cohort study of 1244 individuals.

Mattias Lissing, Daphne Vassiliou, Ylva Floderus

|Jan 24, 2022
RNAi therapy with givosiran significantly reduces attack rates in acute intermittent porphyria.

Eliane Sardh, Pauline Harper

Pageof 2

Frequent Collaborators

4 joint publications

Daphne Vassiliou

4 joint publications

Mattias Lissing

3 joint publications

Staffan Wahlin

2 joint publications

Hannes Hagström